Subsequently they also observed that the carbonyl group on the LamD inner lipid ring as well as the hydroxyl groups on C-8 and C-20 could interact with three critical binding sites Arg 364 Asn 722 Glu

ary complex. This interaction stabilizes the binding of Topo I to the DNA-LamD complex and enhances its ability to cleave and re-ligate the DNA strand.

Furthermore, the researchers found that LamD can inhibit the activity of Topo II, another type of topoisomerase enzyme that is involved in DNA replication and transcription. LamD binds to the ATPase domain of Topo II, blocking its ability to hydrolyze ATP and preventing the enzyme from completing its catalytic cycle.

Overall, these findings suggest that LamD has a unique mechanism of action in inhibiting topoisomerase enzymes, which could potentially be exploited for the development of novel anti-cancer drugs. Further studies are needed to fully understand the molecular details of LamD's interactions with topoisomerases and its potential therapeutic applications.